682 related articles for article (PubMed ID: 15615696)
21. A novel toxin from the venom of the scorpion Tityus trivittatus, is the first member of a new alpha-KTX subfamily.
Abdel-Mottaleb Y; Coronas FV; de Roodt AR; Possani LD; Tytgat J
FEBS Lett; 2006 Jan; 580(2):592-6. PubMed ID: 16405970
[TBL] [Abstract][Full Text] [Related]
22. OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
Abdel-Mottaleb Y; Vandendriessche T; Clynen E; Landuyt B; Jalali A; Vatanpour H; Schoofs L; Tytgat J
Toxicon; 2008 Jun; 51(8):1424-30. PubMed ID: 18471844
[TBL] [Abstract][Full Text] [Related]
23. The new kappa-KTx 2.5 from the scorpion Opisthacanthus cayaporum.
Camargos TS; Restano-Cassulini R; Possani LD; Peigneur S; Tytgat J; Schwartz CA; Alves EM; de Freitas SM; Schwartz EF
Peptides; 2011 Jul; 32(7):1509-17. PubMed ID: 21624408
[TBL] [Abstract][Full Text] [Related]
24. Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels.
Visan V; Fajloun Z; Sabatier JM; Grissmer S
Mol Pharmacol; 2004 Nov; 66(5):1103-12. PubMed ID: 15286210
[TBL] [Abstract][Full Text] [Related]
25. ImKTx88, a novel selective Kv1.3 channel blocker derived from the scorpion Isometrus maculates.
Han S; Hu Y; Zhang R; Yi H; Wei J; Wu Y; Cao Z; Li W; He X
Toxicon; 2011 Feb; 57(2):348-55. PubMed ID: 21194541
[TBL] [Abstract][Full Text] [Related]
26. Potassium channels as therapeutic targets for autoimmune disorders.
Wulff H; Beeton C; Chandy KG
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
[TBL] [Abstract][Full Text] [Related]
27. Molecular cloning, genomic organization and functional characterization of a new short-chain potassium channel toxin-like peptide BmTxKS4 from Buthus martensii Karsch(BmK).
Jiqun S; Xiuling X; Zhijian C; Wanhong L; Yingliang W; Shunyi Z; Xianchun Z; Dahe J; Xin M; Hui L; Wenxin L; Teng W
J Biochem Mol Toxicol; 2004; 18(4):187-95. PubMed ID: 15452884
[TBL] [Abstract][Full Text] [Related]
28. HgeTx1, the first K+-channel specific toxin characterized from the venom of the scorpion Hadrurus gertschi Soleglad.
Schwartz EF; Schwartz CA; Gómez-Lagunas F; Zamudio FZ; Possani LD
Toxicon; 2006 Dec; 48(8):1046-53. PubMed ID: 17030052
[TBL] [Abstract][Full Text] [Related]
29. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
[TBL] [Abstract][Full Text] [Related]
30. Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Bartok A; Toth A; Somodi S; Szanto TG; Hajdu P; Panyi G; Varga Z
Toxicon; 2014 Sep; 87():6-16. PubMed ID: 24878374
[TBL] [Abstract][Full Text] [Related]
31. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
Abbas N; Belghazi M; Abdel-Mottaleb Y; Tytgat J; Bougis PE; Martin-Eauclaire MF
Biochem Biophys Res Commun; 2008 Nov; 376(3):525-30. PubMed ID: 18804453
[TBL] [Abstract][Full Text] [Related]
32. OcyKTx2, a new K⁺-channel toxin characterized from the venom of the scorpion Opisthacanthus cayaporum.
Schwartz EF; Bartok A; Schwartz CA; Papp F; Gómez-Lagunas F; Panyi G; Possani LD
Peptides; 2013 Aug; 46():40-6. PubMed ID: 23684923
[TBL] [Abstract][Full Text] [Related]
33. Three new toxins from the scorpion Pandinus imperator selectively block certain voltage-gated K+ channels.
Rogowski RS; Collins JH; O'Neill TJ; Gustafson TA; Werkman TR; Rogawski MA; Tenenholz TC; Weber DJ; Blaustein MP
Mol Pharmacol; 1996 Nov; 50(5):1167-77. PubMed ID: 8913348
[TBL] [Abstract][Full Text] [Related]
34. OsK2, a new selective inhibitor of Kv1.2 potassium channels purified from the venom of the scorpion Orthochirus scrobiculosus.
Dudina EE; Korolkova YV; Bocharova NE; Koshelev SG; Egorov TA; Huys I; Tytgat J; Grishin EV
Biochem Biophys Res Commun; 2001 Sep; 286(5):841-7. PubMed ID: 11527374
[TBL] [Abstract][Full Text] [Related]
35. A novel scorpion toxin blocking small conductance Ca2+ activated K+ channel.
Xu CQ; He LL; Brône B; Martin-Eauclaire MF; Van Kerkhove E; Zhou Z; Chi CW
Toxicon; 2004 Jun; 43(8):961-71. PubMed ID: 15208029
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the first K⁺ channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris.
Martin-Eauclaire MF; Céard B; Belghazi M; Lebrun R; Bougis PE
Toxicon; 2013 Dec; 75():168-76. PubMed ID: 23523531
[TBL] [Abstract][Full Text] [Related]
37. Solution structure of maurotoxin, a scorpion toxin from Scorpio maurus, with high affinity for voltage-gated potassium channels.
Blanc E; Sabatier JM; Kharrat R; Meunier S; el Ayeb M; Van Rietschoten J; Darbon H
Proteins; 1997 Nov; 29(3):321-33. PubMed ID: 9365987
[TBL] [Abstract][Full Text] [Related]
38. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional consequences of the presence of a fourth disulfide bridge in the scorpion short toxins: solution structure of the potassium channel inhibitor HsTX1.
Savarin P; Romi-Lebrun R; Zinn-Justin S; Lebrun B; Nakajima T; Gilquin B; Menez A
Protein Sci; 1999 Dec; 8(12):2672-85. PubMed ID: 10631983
[TBL] [Abstract][Full Text] [Related]
40. Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin.
Rauer H; Pennington M; Cahalan M; Chandy KG
J Biol Chem; 1999 Jul; 274(31):21885-92. PubMed ID: 10419508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
